Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors



Status:Archived
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:July 2009
End Date:December 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase 1 Safety and Pharmacokinetic Study of ABT-263 in Combination With Paclitaxel in the Treatment of Subjects With Solid Tumors


Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors.


A Phase 1 Safety and Pharmacokinetic Study of ABT-263 in Combination With Paclitaxel in the
Treatment of Subjects With Solid Tumors.


We found this trial at
3
sites
Clinical Trial Facility in Baltimore Maryland
Baltimore, Maryland 21231
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Trial Facility in Durham North Carolina
Durham, North Carolina 27710
?
mi
from
Durham, NC
Click here to add this to my saved trials
UMDNJ-Robert Wood Johnson Medical Center
New Brunswick, New Jersey 08901
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials